imerge update: continuous transfusion independence & disease modification with imetelstat in lr-mds
Published 1 year ago • 241 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:51
analysis of the imerge trial: the disease-modifying potential of imetelstat in lr-mds
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
3:12
prolonged & continuous transfusion independence after imetelstat treatment in the imerge trial
-
2:40
imerge results: efficacy and disease-modifying activity of imetelstat in lr-mds after esa failure
-
1:25
the recent approval of imetelstat in lr-mds based on results of the imerge trial
-
2:57
imetelstat for lr-mds: insights from the imerge trial
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
41:57
the great misunderstanding of eu mdr amendment
-
35:43
what is clinical evaluation under mdr ?
-
7:42
eu mdr transition extension : a complete guide for medical devices
-
2:01
the evolution of bcl2 inhibition in cll
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
2:05
does imetelstat increase the need for platelet transfusions & growth factors in pts with lr-mds?
-
2:38
imetelstat on-target activity correlates with clinical benefits in mds: imerge findings
-
2:33
insights into the results and implications of the commands & imerge studies in lr-mds
-
9:36
imetelstat provides durable transfusion independence in heavily transfused non-del(5q) lr-mds r/...
-
0:48
augusta eye md uses the customizable ehr system ema®
-
2:50
insights into the ca057-003 trial: mezigdomide, tazemetostat & dexamethasone for r/r myeloma
-
3:06
mutsγ-induced dna conformational changes provide insight into its role in meiotic recombination
-
14:12
is lens replacement the answer to presbyopia? with dr imad hakim